John Nieland brings broad management experience, an in-depth research background in immunology and an expertise in the development of biopharmaceuticals and coordination and development of clinical trials. He worked as head of immunology and later director of research at Medigene AG, where he was involved in the development of the AAV-HPV vaccine and held the position of vice president preclinical research at Borean Pharma. John initiated and collaborated on numerous projects, has published more than 30 articles and is the inventor of 15 patents, including several on the AAV vaccine platform. In addition to his scientific experience, John has extensive business experience and is the founder/co-founder of three biotech companies.